AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

IDSE

Published November 13, 2026 · Updated November 14, 2026

Zoo to You S1E2: Psilocybin for Lyme Disease

Read the full story at IDSE

psilocybin or magic mushrooms to individuals that had post-treatment Lyme disease. So, they had a group of 20, uh, people in the study who met CDC.

Post on X

Share this story

Surfaced by this Google Alert

Magic mushrooms